Skip to main content
Clinical Trials/NCT04404972
NCT04404972RecruitingNot Applicable

Incidence of Complications in Brain Death Organ Donors. Retrospective Observational Study.

Brno University Hospital1 site in 1 country50 target enrollmentStarted: April 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
Myocardial dysfunction

Study Overview

Brief Summary

The purpose of the study is to describe the incidence of complications in brain death adult organ donors.

Detailed Description

Pathophysiological changes following brain death may complicate the care of brain death donors. These complications negatively affects function of donated organs. Understanding these complications and its incidence is crucial for their appropriate management. The aim of this retrospective observational study is to evaluate the incidence of complications in adult brain death organ donors. Date will be collected from medical records of eligible patients admitted to intensive care unit for suspected brain death in whom brain death was confirmed and who become organ donors.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •age ≥18 years
  • •confirmed brain death
  • •organ donor

Exclusion Criteria

  • •age under 18 years

Outcomes

Primary Outcomes

Myocardial dysfunction

Time Frame: 48hours prior confirmation of brain death to ICU discharge

Myocardial dysfunction is defined as left ventricle ejection fraction under 50% on trans-thoracic echocardiography or S-T segment depression or elevation or T wave negativity or positive troponin serum level

ARDS

Time Frame: 48hours prior confirmation of brain death to ICU discharge

ARDS is defined and stratified according to Berlin definition

Renal dysfunction

Time Frame: 48hours prior confirmation of brain death to ICU discharge

Renal dysfunction is defined as presence of at least one of these criteria: absolute increase in serum creatinine ≥0.3 mg/dL (≥26.4 μmol/L) or increase in serum creatinine ≥1.5x above baseline or oliguria (urine output \<0.5 mL/kg per hour) for \>6 hours

Coagulopathy

Time Frame: 48hours prior confirmation of brain death to ICU discharge

Coagulopathy is defined as international normalised ratio above 1,5 or platelet count below 100 000 per microliter

Catecholamine storm

Time Frame: 48hours prior confirmation of brain death to ICU discharge

Catecholamine storm is defined as onset of tachycardia and/or hypertension

Diabetes insipidus

Time Frame: 48hours prior confirmation of brain death to ICU discharge

Diabetes insipidus is defines as urine output more than 4ml/kg per hour or urine specific gravity under 1010

Serum lactate level

Time Frame: 48hours prior confirmation of brain death to ICU discharge

Maximal lactate level will be evaluated during ICU stay

Hypotension

Time Frame: 48hours prior confirmation of brain death to ICU discharge

Hypotension is defined as increase of vasoactive drug dose by 20% or systolic blood pressure lower than 90 mmHg or need for fluid resuscitation after initial normovolemia was achieved

Oxygenation index

Time Frame: 48hours prior confirmation of brain death to ICU discharge

Oxygenation index will be calculated as PaO2 divided by FiO2

Hypothermia

Time Frame: 48hours prior confirmation of brain death to ICU discharge

Body temperature below 36°C or need for external warming

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Brno University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ondrej Hrdy

Principal Investigator

Brno University Hospital

Study Sites (1)

Loading locations...

Similar Trials